Welcome to our book review site go-pdf.online!

You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.

Sign up

Principles of Scientific Writing and Biomedical Publication
  • Language: en
  • Pages: 385

Principles of Scientific Writing and Biomedical Publication

"Publication of biomedical research is essential for improvement and advancement of medical science and clinical practice. The history of scientific publication, including journals devoted to medical science, dates to the 1600s. The number of peer-reviewed scientific journals is estimated to be in the tens of thousands, and the number of journals, especially with the increasing creation of open access publications, continues to expand. Yet, despite the long history of and ubiquitous nature of scientific publications, the core principles involved in biomedical publication as well as the specific skills of writing and manuscript preparation are not commonly taught in a formal or comprehensive way in medicine, public health, or research curricula"--

Embargoed Science
  • Language: en
  • Pages: 163

Embargoed Science

The popular notion of a lone scientist privately toiling long hours in a laboratory, striking upon a great discovery, and announcing it to the world is a romanticized fiction. Vincent Kiernan's Embargoed Science reveals the true process behind science news: an elite few scholarly journals control press coverage through a mechanism known as an embargo. The journals distribute advance copies of their articles to hundreds and sometimes thousands of journalists around the world, on the condition that journalists agree not to report their stories until a common time, several days later. When the embargo lifts, airwaves and newspaper pages are flooded with stories based on the journal's latest iss...

Law and Ethics in Biomedical Research
  • Language: en
  • Pages: 281

Law and Ethics in Biomedical Research

When a young man named Jesse Gelsinger died in 1999 as a result of his participation in a gene transfer research study, regulatory agencies in the United States began to take a closer look at what was happening in medical research. The resulting temporary shutdown of some of the most prestigious academic research centres confirmed what various recent reports in the United States as well as Canada had claimed; that the current system of regulatory oversight was in need of improvement. Law and Ethics in Biomedical Research uses the Gelinger case as a touchstone, illustrating how three major aspects of that case - the flaws in the regulatory system, conflicts of interest, and legal liability - ...

Complementary and Alternative Medicine in the United States
  • Language: en
  • Pages: 360

Complementary and Alternative Medicine in the United States

Integration of complementary and alternative medicine therapies (CAM) with conventional medicine is occurring in hospitals and physicians offices, health maintenance organizations (HMOs) are covering CAM therapies, insurance coverage for CAM is increasing, and integrative medicine centers and clinics are being established, many with close ties to medical schools and teaching hospitals. In determining what care to provide, the goal should be comprehensive care that uses the best scientific evidence available regarding benefits and harm, encourages a focus on healing, recognizes the importance of compassion and caring, emphasizes the centrality of relationship-based care, encourages patients t...

Conflicts of Interest and the Future of Medicine
  • Language: en
  • Pages: 392

Conflicts of Interest and the Future of Medicine

In this book, Marc Rodwin examines the development of conflicts of interest in the health care systems of the US, France, and Japan. He shows that national differences in the organization of medical practice and the interplay of organized medicine, the market, and the state give rise to variations in the type and prevalence of such conflicts, and then analyzes the strategies that each nation employs to cope with them. Drawing on the experiences of these three nations, Conflicts of Interest and the Future of Medicine demonstrates that we can mitigate these problems with carefully planned reform and regulation.

Modelling Scientific Communities
  • Language: en
  • Pages: 172

Modelling Scientific Communities

This Element will overview research using models to understand scientific practice. Models are useful for reasoning about groups and processes that are complicated and distributed across time and space, i.e., those that are difficult to study using empirical methods alone. Science fits this picture. For this reason, it is no surprise that researchers have turned to models over the last few decades to study various features of science. The different sections of the element are mostly organized around different modeling approaches. The models described in this element sometimes yield take-aways that are straightforward, and at other times more nuanced. The Element ultimately argues that while these models are epistemically useful, the best way to employ most of them to understand and improve science is in combination with empirical methods and other sorts of theorizing.

The Cure for Everything
  • Language: en
  • Pages: 257

The Cure for Everything

  • Type: Book
  • -
  • Published: 2013-04-09
  • -
  • Publisher: Beacon Press

A bold look at how commercial agendas distort the real science behind health and fitness studies and misinform the public about how to live a healthy life. Researcher Timothy Caulfield talks with experts in medicine, pharmaceuticals, health and fitness, and even tries out many of the health fads himself, in order to test their scientific validity, dispel the myths, and illuminate the path to better health.

Drugs and Justice
  • Language: en
  • Pages: 308

Drugs and Justice

  • Categories: Law

This compact and innovative book tackles one of the central issues in drug policy: the lack of a coherent conceptual structure for our thinking about drugs. Battin and her contributors lay a foundation for a wiser drug policy by promoting consistency and coherency in the discussion of drug issues and by encouraging a unique dialogue across disciplines. The book is written accessibly with little need for expert knowledge, and will appeal to a diverse audience of philosophers, bioethicists, clinicians, policy makers, law enforcement, legal scholars and practitioners, social workers, and general readers, as well as to students in areas like pharmacy, medicine, law, nursing, sociology, social work, psychology, and bioethics.

What's Our Problem?
  • Language: en
  • Pages: 388

What's Our Problem?

  • Type: Book
  • -
  • Published: 2023-02-21
  • -
  • Publisher: Wait But Why

From the creator of the wildly popular blog Wait But Why, a fun and fascinating deep dive into what the hell is going on in our strange, unprecedented modern times. Between 2013 and 2016, Tim Urban became one of the world’s most popular bloggers, writing dozens of viral, long-form articles about everything from AI to colonizing Mars to procrastination. Then, he turned his attention to a new topic: the society around him. Why was everything such a mess? Why was everyone acting like such a baby? When did things get so tribal? Why do humans do this stuff? This massive topic sent Tim tumbling down his deepest rabbit hole yet, through mountains of history, evolutionary psychology, political the...

Profits before People?
  • Language: en
  • Pages: 225

Profits before People?

The pharmaceutical industry has come under intense criticism in recent years. One poll found that 70% of the sample agreed that drug companies put profits ahead of people. Is this perception accurate? Have drug companies traded ethics for profits and placed people at risk? In Profits before People? Leonard J. Weber exposes pharmaceutical industry practices that have raised ethical concerns. Providing systematic ethical analysis and reflection, he discusses such practices as compensating physicians for serving as speakers or consultants, providing incentives to physicians to enroll patients as subjects in clinical research, and advertising prescription drugs to the public through the mass med...